During this segment, Peter Salgo, MD, defines clinical inertia and explains how it can result in unnecessary, damaging hyperglycemia events that can persist for years in some patients. Additionally, he notes that clinical inertia contributes to costly health complications, higher rates of hospitalizations, and an overall increased use of healthcare resources.
For this reason, Dr Salgo and the panelists explore how healthcare organizations have implemented programs to incentivize healthy behaviors in diabetes patients.
Kari Uusinarkaus, MD, FAAFP, FNLA, discusses how his group has implemented a disease management program that connects an RN “Nurse Navigator” to a patient during hospital discharge. Dr Uusinarkaus explains the importance of this initiative, and highlights another program, called Silver Sneakers, that provides gym access to patients older than 60 years.
However, the panelists recognize that not all initiatives have been successful. For example, despite reducing or limiting the copayments for type 2 diabetes mellitus and obesity drugs, according to Jeffrey D. Dunn, PharmD, MBA, no reliable source of data has revealed changes in patient behavior or improvements in overall outcomes that have come as a result of this reduced cost burden.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More